Exploring Left-Hand-Side substitutions in the benzoxazinone series of 4-amino-piperidine bacterial type IIa topoisomerase inhibitors (original) (raw)
Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents
Peter Meinke
ACS Medicinal Chemistry Letters, 2014
View PDFchevron_right
De Novo Design of Type II Topoisomerase Inhibitors as Potential Antimicrobial Agents Targeting a Novel Binding Region
Thomas Germe
2021
View PDFchevron_right
Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV
Thuỳ An Hoàng
Bioorganic & Medicinal Chemistry Letters, 2013
View PDFchevron_right
Cyclohexyl amide-based novel bacterial topoisomerase inhibitors with prospective GyrA-binding fragments
Martina Hrast
Future Medicinal Chemistry, 2019
View PDFchevron_right
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: Synthesis and antibacterial activity
Brian Dymock
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5)
Yasumichi Fukuda
Bioorganic & Medicinal Chemistry Letters, 2015
View PDFchevron_right
Structure–activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors
Dai Nguyen
Bioorganic & Medicinal Chemistry Letters, 2007
View PDFchevron_right
Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria
bhavesh dhumale
Journal of Medicinal Chemistry, 2021
View PDFchevron_right
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: A Suitable Scaffold for the Development of Noncamptothecin Topoisomerase I (Top1) Inhibitors
Keli Agama
Journal of Medicinal Chemistry, 2013
View PDFchevron_right
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitors
Sandro Cosconati, Keli Agama
Journal of medicinal chemistry, 2013
View PDFchevron_right
New developments in non-quinolone-based antibiotics for the inhibiton of bacterial gyrase and topoisomerase IV
Asad Ullah
European journal of medicinal chemistry, 2018
View PDFchevron_right
Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs)
Marko Anderluh
Journal of Medicinal Chemistry
View PDFchevron_right
Type IIA topoisomerase inhibition by a new class of antibacterial agents
Alexandre Wohlkonig
Nature, 2010
View PDFchevron_right
Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against Acinetobacter baumannii and Pseudomonas aeruginosa
Davide Benedetto Tiz
Journal of Medicinal Chemistry, 2023
View PDFchevron_right
Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria
Mark Craighead
Antimicrobial agents and chemotherapy, 2017
View PDFchevron_right
Left hand side exploration of novel bacterial topoisomerase inhibitors to improve selectivity against hERG binding
Gajanan Shanbhag, Jayashree Puttur, Anandkumar Raichurkar
ACS Medicinal Chemistry Letters, 2015
View PDFchevron_right
Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa
Thomas Dougherty
Bioorganic & Medicinal Chemistry, 2014
View PDFchevron_right
Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multi-Drug Resistant Gram-Negative Bacteria
Marla Weetall
Journal of medicinal chemistry, 2018
View PDFchevron_right
In vitro and in vivo characterization of the novel oxabicyclooctane-linked bacterial topoisomerase inhibitor (NTBI) AM-8722: a selective, potent inhibitor of bacterial DNA gyrase
Yasumichi Fukuda
Antimicrobial agents and chemotherapy, 2016
View PDFchevron_right
Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity
Thanh Lam
Bioorganic & Medicinal Chemistry Letters, 2013
View PDFchevron_right